Search research articles
Contact Us
Filters
Showing results (171-180 of 180) with videos related to
Page
of 18
Sort By:
You have reached the last page of results.
This site can display upto 180 results.
Journal of Experimental & Clinical Cancer Research : CR
|
July 6, 2022
Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers
Capucine Baldini, Francois-Xavier Danlos, Andreea Varga, et al.
Nature
|
September 7, 2022
Genomics to select treatment for patients with metastatic breast cancer
Fabrice Andre, Thomas Filleron, Maud Kamal, et al.
Ebiomedicine
|
June 1, 2022
Dynamics of circulating calprotectin accurately predict the outcome of moderate COVID-19 patients
Nicolas Chapuis, Nusaibah Ibrahimi, Thibaut Belmondo, et al.
Radiology
|
November 26, 2024
Liquid Biopsy versus CT: Comparison of Tumor Burden Quantification in 1065 Patients with Metastases
Lama Dawi, Younes Belkouchi, Littisha Lawrance, et al.
Cancer Discovery
|
January 20, 2023
Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti-PD-1 + Antiangiogenesis in Malignant Pleural Mesothelioma
François-Xavier Danlos, Matthieu Texier, Bastien Job, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2019
Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer
Gonzalo Recondo, Laura Mezquita, Francesco Facchinetti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2026
Phase I/II study of the PARP inhibitor olaparib and irinotecan in children and young adults with recurrent/refractory malignancies: Arm D of the AcSé-ESMART trial
Susanne A Gatz, Pablo Berlanga, Gwénaël Le Teuff, et al.
Thyroid : Official Journal of the American Thyroid Association
|
October 16, 2023
Association of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter Study
Bin Xu, Kartik Viswanathan, Mahsa S Ahadi, et al.
Oncotarget
|
May 7, 2015
A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancer
Vladimir Lazar, Eitan Rubin, Stephane Depil, et al.
Nature
|
October 9, 2024
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, et al.
Page
of 18
Search research articles
Search
Showing results (171-180 of 180) with videos related to
Sort By:
Page
of 18
You have reached the last page of results.
This site can display upto 180 results.
Journal of Experimental & Clinical Cancer Research : CR
|
July 6, 2022
Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers
Capucine Baldini, Francois-Xavier Danlos, Andreea Varga, et al.
Nature
|
September 7, 2022
Genomics to select treatment for patients with metastatic breast cancer
Fabrice Andre, Thomas Filleron, Maud Kamal, et al.
Ebiomedicine
|
June 1, 2022
Dynamics of circulating calprotectin accurately predict the outcome of moderate COVID-19 patients
Nicolas Chapuis, Nusaibah Ibrahimi, Thibaut Belmondo, et al.
Radiology
|
November 26, 2024
Liquid Biopsy versus CT: Comparison of Tumor Burden Quantification in 1065 Patients with Metastases
Lama Dawi, Younes Belkouchi, Littisha Lawrance, et al.
Cancer Discovery
|
January 20, 2023
Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti-PD-1 + Antiangiogenesis in Malignant Pleural Mesothelioma
François-Xavier Danlos, Matthieu Texier, Bastien Job, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2019
Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer
Gonzalo Recondo, Laura Mezquita, Francesco Facchinetti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2026
Phase I/II study of the PARP inhibitor olaparib and irinotecan in children and young adults with recurrent/refractory malignancies: Arm D of the AcSé-ESMART trial
Susanne A Gatz, Pablo Berlanga, Gwénaël Le Teuff, et al.
Thyroid : Official Journal of the American Thyroid Association
|
October 16, 2023
Association of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter Study
Bin Xu, Kartik Viswanathan, Mahsa S Ahadi, et al.
Oncotarget
|
May 7, 2015
A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancer
Vladimir Lazar, Eitan Rubin, Stephane Depil, et al.
Nature
|
October 9, 2024
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, et al.
Page
of 18